(Q59616896)
Statements
[Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)] (English)
C Wenzel
M Schmidinger
G J Locker
S Taucher
R Jakesz